Real|world treatment patterns and outcomes of patients ...

Real-world treatment patterns and outcomes of patients with small ...

Current treatments utilized in the 3L-plus setting yield limited survival benefit. Furthermore, patients left untreated and placed on BSC typically live less ...

Real-world treatment patterns and outcomes of patients ... - PubMed

Patients with progressive mNSq NSCLC most commonly received later-line docetaxel for cancer without driver mutations, or platinum-based chemotherapy.

Real-world treatment patterns and outcomes in patients with HR+ ...

This real-world study describes treatment patterns and outcomes in patients treated with chemotherapy in the United States before approval of antibody–drug ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

In 561 patients with 1 prior LOT at inclusion, the cumulative attrition rate from LOT 2 to 5 was 85%, which included 25% patients who died and ...

Real-world treatment patterns and outcomes of patients with ...

Patients with progressive mNSq NSCLC most commonly received later-line docetaxel for cancer without driver mutations, or platinum-based chemotherapy.

Real-World Treatment Patterns and Clinical Outcomes After ...

PURPOSETo characterize treatment patterns and real-world clinical outcomes of patients with metastatic non–small cell lung cancer (mNSCLC) ...

Real-World Treatment Patterns and Outcomes of Patients with ...

This real-world data suggests that MM treatment evolves rapidly following the reimbursement of new novel drugs, to treat patients with the most optimal ...

Recent real-world treatment patterns and outcomes in US patients ...

Median rwPFS (95% confidence interval [CI]) declined from 12.0 months (10.9, 13.4) at first-line to 2.9 months (2.3, 4.0) at fourth-line. Median ...

US real-world first-line (1L) treatment patterns and outcomes for ...

Results: A total of 249 eligible mUC patients initiated 1L treatment. Of these, 132 (53%) received ICI monotherapy, 99 (40%) received platinum- ...

P09.23 Real-World Treatment Patterns and Outcomes in Patients ...

In this real-world study, we assessed patient characteristics, treatment patterns, and overall survival (OS) in patients with NSCLC using Public Health ...

Real-World Treatment Patterns and Outcomes of First-Line ...

Our objectives were to summarize characteristics and treatment patterns for patients with four little-studied genomic alterations or driver-negative NSCLC.

Real-world patient characteristics and treatment patterns in US ...

Patients from non-small cell lung cancer (NSCLC) controlled clinical trials do not always reflect real-world heterogeneous patient ...

P2.31-06 Real-World Treatment Patterns and Outcomes in Patients ...

Conclusions. This RW study describes the limited treatment options and quantifies the poor prognosis of patients with aNSCLC who are treated after prior ...

Real-world treatment patterns and clinical outcomes in patients with ...

This study provides insights into real-world treatment patterns and clinical outcomes in patients with PC.

Real-world treatment patterns and outcomes for patients with ...

We describe the characteristics, treatment patterns and clinical outcomes for patients with newly diagnosed multiple myeloma (NDMM) over 2010–2018.

Real-world treatment patterns and outcomes of patients with ...

Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in ...

Real-World Clinical Outcomes and Treatment Patterns Among Black ...

By Benjamin H. Lowentritt, Carmine Rossi & 6 more. This study describes real-world treatment patterns and clinical outcomes among patients ...

Real-World Treatment Patterns and Clinical Outcomes Among ...

Elizabeth Esterberg,1 Shrividya Iyer,2 Saurabh P. Nagar,1 Keith L. Davis,1. Nizar M. Tannir3. Abstract. This real-world study of patients with renal cell ...

Real-world treatment patterns and outcomes of patients with ...

The NIVO-RELA combination results in synergistic antitumor activity with increased effector T-cell activity in the tumor microenvironment.4 ...

Real-world treatment patterns and survival outcomes for patients ...

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.